Antibodies against human herpesvirus 8 in black South African patients with cancer.
about
Seroprevalence and risk factors of Kaposi's sarcoma-associated herpesvirus infection among the general Uygur population from south and north region of Xinjiang, ChinaHuman herpesvirus 8--a novel human pathogenRisk factors for high anti-HHV-8 antibody titers (> or =1:51,200) in black, HIV-1 negative South African cancer patients: a case control studyThe Durban DeclarationPlasma antibodies against Chlamydia trachomatis, human papillomavirus, and human herpesvirus type 8 in relation to prostate cancer: a prospective studyHuman herpesvirus 8 seropositivity among sexually active adults in UgandaSeroprevalence of Kaposi's sarcoma-associated herpesvirus and risk factors in Xinjiang, ChinaKaposi's Sarcoma–Associated Herpesvirus Immunoevasion and Tumorigenesis: Two Sides of the Same Coin?Epidemiology and pathogenesis of Kaposi's sarcoma-associated herpesvirus.Reactivation of Kaposi's sarcoma-associated herpesvirus by natural products from Kaposi's sarcoma endemic regions.Spectrum of Kaposi's sarcoma-associated herpesvirus, or human herpesvirus 8, diseasesViral load of human herpesvirus 8 in peripheral blood of human immunodeficiency virus-infected patients with Kaposi's sarcoma.HIV and cancer in Africa: mutual collaboration between HIV and cancer programs may provide timely research and public health data.Sex and geographic patterns of human herpesvirus 8 infection in a nationally representative population‐based sample in Uganda.Injectable and oral contraceptive use and cancers of the breast, cervix, ovary, and endometrium in black South African women: case-control study.Carcinogenic viruses and solid cancers without sufficient evidence of causal association.Charting latency transcripts in Kaposi's sarcoma-associated herpesvirus by whole-genome real-time quantitative PCRHHV-8 infection: a model for reactivation and transmission.Mechanisms of expression of HHV8, EBV and HPV in selected HIV-associated oral lesions.Prospective study of human herpesvirus type 8 serostatus and prostate cancer risk in the placebo arm of the Prostate Cancer Prevention Trial.Calibrated real-time PCR assay for quantitation of human herpesvirus 8 DNA in biological fluids.Molecular genetics of Kaposi's sarcoma-associated herpesvirus (human herpesvirus-8) epidemiology and pathogenesis.Review of the distribution of Kaposi's sarcoma-associated herpesvirus (KSHV) in Africa in relation to the incidence of Kaposi's sarcomaIs there a role for microorganisms in the pathogenesis of sarcoidosis?Human herpesvirus 6 activates lytic cycle replication of Kaposi's sarcoma-associated herpesvirusAntibodies against six human herpesviruses in relation to seven cancers in black South Africans: a case control study.Heterogeneity and breadth of host antibody response to KSHV infection demonstrated by systematic analysis of the KSHV proteomeSerodiagnosis for tumor viruses.Parasite infection is associated with Kaposi's sarcoma associated herpesvirus (KSHV) in Ugandan women.Kaposi's Sarcoma in HIV-infected patients in South Africa: Multicohort study in the antiretroviral therapy era.Prevalence and predictors of kaposi sarcoma herpes virus seropositivity: a cross-sectional analysis of HIV-infected adults initiating ART in Johannesburg, South AfricaThe relationship between anti-HPV-16 IgG seropositivity and cancer of the cervix, anogenital organs, oral cavity and pharynx, oesophagus and prostate in a black South African population.Induction of HHV-8 lytic cycle replication by inflammatory cytokines produced by HIV-1-infected T cells.Prostate carcinogenesis and inflammation: emerging insights.Trends in Kaposi's sarcoma-associated Herpesvirus antibodies prior to the development of HIV-associated Kaposi's sarcoma: a nested case-control study.Kaposi's sarcoma-associated herpesvirus: clinical, diagnostic, and epidemiological aspects.AIDS-related Kaposi's sarcoma: epidemiological, diagnostic, treatment and control aspects in sub-Saharan Africa.Conceptual emergence of human herpesvirus 8 (Kaposi's sarcoma-associated herpesvirus) as an oral herpesvirus.Trends in Kaposi's Sarcoma in Miami Beach from 1987 to 2007A prospective study of Kaposi's sarcoma-associated herpesvirus and Epstein-Barr virus in adults with human immunodeficiency virus-1
P2860
Q21245098-A513244C-79C7-4B66-916D-32A1E2603140Q24530670-99367716-4C98-4CF6-8C50-67295F0C9D9EQ24804288-DD452628-E053-4B65-B410-AA6E14CC3B25Q28140757-4E181FF4-C506-41A1-AF9A-FFAE4188C0E6Q28219236-0B893E50-A5B3-4577-8FE6-F525CC4174A8Q28743392-199287AB-11E1-4FCA-A8D0-86F71FF77DDAQ28750969-40109D53-D924-42EE-8D24-C3C06EBA2FFAQ29394711-2886D805-B26A-4582-A211-3F18A664B174Q33772234-F636E452-722A-40DD-A555-4F7C86FE7B64Q33803534-C75E9DCD-D69F-48FF-87C2-F91F42FD6EB5Q33906970-D2E41E0D-6ED1-49CE-9A80-B5712902A2DEQ33974199-9489027F-4CA6-48AE-8E48-E729832689C8Q34049757-633F62D8-812F-4654-BE5D-B9848225C9E6Q34172766-E6C295D8-171B-4F43-B863-53671AACB30BQ34192784-8680178E-185E-4CD1-A5B3-1F1567FC2D11Q34320412-098CD9EC-31E0-400F-9D24-1BCAB14D321FQ34340317-5345FEC3-B002-47E9-A03B-0CBFA1054D1DQ34490261-55EB6C99-25BC-4FDC-84F3-B82DD71CB9DBQ34775238-031847A1-6FA2-495C-A5CF-B6EFF4C38177Q34810223-9E94E7E6-AF2C-45CA-BB17-A7FC07011959Q34988603-CAB9F278-62A3-436B-8B64-CB29E55C2638Q35026060-A53EAEA1-E624-401C-B690-0520E1B4C6BBQ35056369-3BFA78C1-D0E9-43F9-88D1-852008E01F46Q35067110-D46988F7-6957-40CA-8CCA-08A7B8F51A10Q35083522-916EB044-AF83-48A9-9E04-3DE802B90765Q35127217-52643BB6-77F5-4FE6-8F71-FBBBD879D03EQ35133590-EEB4B714-195A-4227-9A3B-D4394765A73AQ35289576-6BF28D2A-C0B3-43E7-B334-28D3984FEAB9Q35397565-7581D68B-C21C-41B0-BF75-2B301DD0C746Q35557475-59FFF045-1C8D-4411-8616-228931FCFC6FQ35632074-E103A8CD-44DC-4168-946D-0B5E0550B30AQ35677525-74C182F9-416F-4F1C-A1CE-049CB896DB83Q35745497-889A2AC7-02CB-4DFC-9C71-3C7196B8D52BQ35925066-56EBBB49-11E0-4A95-A51C-960263DDFFE6Q35929961-2FBA312F-000F-4B2F-AE63-5A7025D06446Q36154559-AAEB79EB-E5A7-4926-99B5-F90343703DCDQ36268446-FF6C4B91-53B5-4B7F-A540-CC9EAB86F100Q36467678-2A47F7BD-8A9D-4F9C-877E-379FA9E5D162Q36520006-41FE0471-5750-426E-963C-EAE51299070AQ36614200-AD1D414C-7286-40BC-AFC0-9F345342EB34
P2860
Antibodies against human herpesvirus 8 in black South African patients with cancer.
description
1999 nî lūn-bûn
@nan
1999 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի հունիսին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Antibodies against human herpesvirus 8 in black South African patients with cancer.
@ast
Antibodies against human herpesvirus 8 in black South African patients with cancer.
@en
type
label
Antibodies against human herpesvirus 8 in black South African patients with cancer.
@ast
Antibodies against human herpesvirus 8 in black South African patients with cancer.
@en
prefLabel
Antibodies against human herpesvirus 8 in black South African patients with cancer.
@ast
Antibodies against human herpesvirus 8 in black South African patients with cancer.
@en
P2093
P1476
Antibodies against human herpesvirus 8 in black South African patients with cancer
@en
P2093
Bourboulia D
P304
P356
10.1056/NEJM199906173402403
P407
P577
1999-06-01T00:00:00Z